dc.contributor.author | Yenilmez, E. N. | |
dc.contributor.author | Yaylim, I. | |
dc.contributor.author | Kafadar, A. | |
dc.contributor.author | Cacina, C. | |
dc.contributor.author | Ozkok, E. | |
dc.contributor.author | Kucukhuseyin, Özlem | |
dc.contributor.author | Kafadar, D. | |
dc.contributor.author | Turan, S. | |
dc.date.accessioned | 2021-03-06T07:44:32Z | |
dc.date.available | 2021-03-06T07:44:32Z | |
dc.identifier.citation | Kafadar A., Kucukhuseyin Ö., Cacina C., Yenilmez E. N. , Turan S., Kafadar D., Ozkok E., Yaylim I., "Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors?", FEBS EMBO 2014 Conference, Paris, Fransa, 30 Ağustos - 04 Eylül 2014, cilt.281, ss.76 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_ddad2eb1-99b7-44c7-b643-3598affc3fa3 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/146056 | |
dc.language.iso | eng | |
dc.subject | Cancer Research | |
dc.subject | Molecular Biology | |
dc.subject | Drug Discovery | |
dc.subject | Aging | |
dc.subject | General Biochemistry, Genetics and Molecular Biology | |
dc.subject | Biochemistry | |
dc.subject | Structural Biology | |
dc.subject | Life Sciences | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Temel Bilimler | |
dc.subject | Biochemistry, Genetics and Molecular Biology (miscellaneous) | |
dc.subject | Clinical Biochemistry | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Yaşam Bilimleri | |
dc.title | Is there any relation between CDKN2 p16 and MDM2 variants and the development of primary brain tumors? | |
dc.type | Bildiri | |
dc.contributor.department | Istanbul Bagcilar Training & Research Hospital , , | |
dc.identifier.volume | 281 | |
dc.contributor.firstauthorID | 144968 | |